Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Idiopathic Thrombocytopenic Purpura”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Post-approval studies (Phase 4)Study completedNCT04638829
What this trial is testing

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 60
Large-scale testing (Phase 3)Study completedNCT05422365
What this trial is testing

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Biopharma Plasma LLC 32
Large-scale testing (Phase 3)Study completedNCT00504075
What this trial is testing

Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Chronic Idiopathic Thrombocytopenic Purpura
Bio Products Laboratory 35
Testing effectiveness (Phase 2)Study completedNCT00049725
What this trial is testing

Daclizumab to Treat Chronic Immune Thrombocytopenia

Who this might be right for
Thrombocytopenia
National Institutes of Health Clinical Center (CC) 24
Testing effectiveness (Phase 2)Ended earlyNCT00547066
What this trial is testing

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Autoimmune
Gilead Sciences 48
Large-scale testing (Phase 3)Study completedNCT00774202
What this trial is testing

Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Weill Medical College of Cornell University 17
Large-scale testing (Phase 3)Ended earlyNCT01226524
What this trial is testing

The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP)

Who this might be right for
Childhood Chronic Immune Thrombocytopenia
Hadassah Medical Organization 7
Not applicableStudy completedNCT03412188
What this trial is testing

The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Nayera Hazaa Elsherif 36
Large-scale testing (Phase 3)WithdrawnNCT02649504
What this trial is testing

Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University
Not applicableStudy completedNCT01416311
What this trial is testing

Drug Use Investigation for REVOLADE (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
Novartis Pharmaceuticals 5,797
Early research (Phase 1)Study completedNCT03275454
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Bioverativ, a Sanofi company 12
Large-scale testing (Phase 3)Ended earlyNCT04200456
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 33
Large-scale testing (Phase 3)Ended earlyNCT04224688
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 30
Large-scale testing (Phase 3)Study completedNCT05369208
What this trial is testing

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 19
Early research (Phase 1)Study completedNCT00001630
What this trial is testing

Treatment of Autoimmune Thrombocytopenia (AITP)

Who this might be right for
Autoimmune DiseaseAutoimmune Hemolytic AnemiaThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 29
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083739
What this trial is testing

A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 320
Testing effectiveness (Phase 2)Study completedNCT00860600
What this trial is testing

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
PhytoHealth Corporation 14
Testing effectiveness (Phase 2)Ended earlyNCT02401061
What this trial is testing

PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT04056195
What this trial is testing

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Oscotec Inc. 61
Testing effectiveness (Phase 2)Study completedNCT00162006
What this trial is testing

Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Baxalta now part of Shire 28
Load More Results